Project support for a Phase 1 clinical trial of new broadly neutralizing anti-HIV monoclonal antibodies (bnAbs) to assess their safety and potential to prevent vertical HIV transmission in infants
Project support to test and treat approximately 11,000 people suffering from visceral leishmaniasis per year